Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICD-10 Heads To Full NCVHS With Unanimous Subcommittee Support

This article was originally published in The Gray Sheet

Executive Summary

ICD-10 code set adoption will aid CMS in making coverage and payment decisions based on patients' conditions, symptoms and diagnoses, according to Tom Grissom, director of the agency's Center for Medicare Management

You may also be interested in...



ICD-10 Implementation May Win Support Of President’s IT Panel

The President's Information Technology Advisory Committee likely will recommend moving forward with ICD-10 coding implementation, even though a subcommittee has urged adopting SNOMED CT as an alternative

ICD-10 Implementation May Win Support Of President’s IT Panel

The President's Information Technology Advisory Committee likely will recommend moving forward with ICD-10 coding implementation, even though a subcommittee has urged adopting SNOMED CT as an alternative

Permanent LVAD Implants Appropriate For End-Stage Heart Failure – CMS

Left-ventricular assist device implants for destination therapy will be limited to 60 U.S. centers under the terms of a positive CMS national coverage determination for the therapy, Thoratec estimates

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019251

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel